Post-marketing surveillance study on the effectiveness and safety of molnupiravir in high-risk COVID-19 outpatients: a prospective case series study
Molnupiravir appears to show good safety and effectiveness, offering an alternative for high-risk COVID-19 outpatients ineligible for first-line therapy. Despite its market withdrawal, ongoing research into its long-term effects is crucial to potentially repurpose it for other viral infections.
Authors
- Fátima Falcão (ORCID: https://orcid.org/0000-0002-2860-061X)
- Sofia Baptista (ORCID: https://orcid.org/0000-0002-2604-9369)
- Cristina Santos (ORCID: https://orcid.org/0000-0002-7109-1101)
- Inês Ribeiro‐Vaz (ORCID: https://orcid.org/0000-0002-3442-8158)
- Renato Ferreira‐da‐Silva (ORCID: https://orcid.org/0000-0001-6517-6021)
- Marta Cristiane Alves Pereira (ORCID: https://orcid.org/0000-0002-0563-215X)
- Ana Mirco (ORCID: https://orcid.org/0000-0001-9668-7561)
- Helena Farinha (ORCID: https://orcid.org/0000-0003-3243-1617)
- Manuela Morato (ORCID: https://orcid.org/0000-0002-9509-0613)
- Maria Celeste Nunes de Melo (ORCID: https://orcid.org/0000-0002-9826-4981)
- Lesly Calixto-Aguilar (ORCID: https://orcid.org/0000-0001-9202-0831)
- Jorge Polónia (ORCID: https://orcid.org/0000-0002-0133-7217)
- Manuela Pinto (ORCID: https://orcid.org/0009-0008-8759-1486)
- I. Figueira
- Lurdes Silva (ORCID: https://orcid.org/0009-0000-7221-7856)
Institutions
- San Antonio College (US)
- Universidade do Porto (PT)
- Hospital de São João (PT)
- Hospital do Divino Espírito Santo (PT)
- Centro Hospitalar de Lisboa Ocidental (PT)
- Hospital de Santo António (PT)
- Healthwise (US)
- Decision Sciences (United States) (US)
- Centre for Health Technology and Services Research (PT)
- Rede de Química e Tecnologia (PT)
- Centro Hospitalar de Vila Nova de Gaia (PT)
Publication Details
- Journal
- Pharmacological Reports
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1007/s43440-025-00729-2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidade do Porto